EMA increase of fees from 1 April 2018

Every year, the European Medicines Agency (EMA)  adjusts its fees on 1 April, in line with the European Union (EU) inflation rate for the previous year. On 1 April 2018 general, non-pharmacovigilance fees payable to EMA by applicants and marketing-authorisation holders (MAH) are increasing by 1.7%. Applications received after the 31 March 2018 will be charged the…

Food supplements containing melatonin

Melatonin is an hormone secreted naturally during the night. Among other things, melatonin promotes sleep, modules mood and the immune system, regulates the body temperature and the intestinal motricity. In France, melatonin is used in medicinal products, extemporaneous preparations and food supplements. Since the implementation of the Nutrivigilance scheme in 2009 and until May 2017, ANSES…

No health risks to people living outside of Japan from damaged nuclear plants

There are no health risks so far to people living in other countries from radioactive material released into the atmosphere from the Japanese nuclear power plants. Radiation levels measured to date in other countries are far below the level of background radiation that most people are exposed to in normal everyday circumstances. Source: WHO –…